NCT05195372View on ClinicalTrials.gov

Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

April 30, 2022

Study Completion Date

July 31, 2022

Conditions
Antiphospholipid SyndromeVenous ThromboembolismArterial ThromboembolismMajor Bleed
Trial Locations (1)

60389

Edelgard Lindhoff-Last, Frankfurt am Main

All Listed Sponsors
lead

Cardioangiologisches Centrum Bethanien

OTHER

NCT05195372 - Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome | Biotech Hunter | Biotech Hunter